These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 20833336)

  • 1. Mouse models of endocrine tumours.
    Jones GN; Manchanda PK; Pringle DR; Zhang M; Kirschner LS
    Best Pract Res Clin Endocrinol Metab; 2010 Jun; 24(3):451-60. PubMed ID: 20833336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Broad tumor spectrum in a mouse model of multiple endocrine neoplasia type 1.
    Loffler KA; Biondi CA; Gartside M; Waring P; Stark M; Serewko-Auret MM; Muller HK; Hayward NK; Kay GF
    Int J Cancer; 2007 Jan; 120(2):259-67. PubMed ID: 17044021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathological profile as a basis for classification of the endocrine tumours of the gastroenteropancreatic tract.
    Solcia E; Rindi G; Paolotti D; La Rosa S; Capella C; Fiocca R
    Ann Oncol; 1999; 10 Suppl 2():S9-15. PubMed ID: 10399027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endocrine tumours in neurofibromatosis type 1, tuberous sclerosis and related syndromes.
    Lodish MB; Stratakis CA
    Best Pract Res Clin Endocrinol Metab; 2010 Jun; 24(3):439-49. PubMed ID: 20833335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A proteomic approach of the endocrine tumors].
    Diaz JJ; Couderc C; Couté Y; Poncet G; Pourpe S; Hacot S; Borson-Chazot F; Aguerra K; Scoazec JY; Sanchez JC; Roche C
    Ann Endocrinol (Paris); 2008 Apr; 69(2):138-42. PubMed ID: 18423423
    [No Abstract]   [Full Text] [Related]  

  • 6. HEREDITARY ENDOCRINE TUMOURS: CURRENT STATE-OF-THE-ART AND RESEARCH OPPORTUNITIES: Challenges and opportunities in genetic counseling for hereditary endocrine neoplasia syndromes.
    Brock P; Geurts JL; Van Galen P; Blouch E; Welch J; Kunz A; Desrosiers L; Gauerke J; Hyde S
    Endocr Relat Cancer; 2020 Aug; 27(8):T65-T75. PubMed ID: 32106089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoclonality of endocrine tumours: What does it mean?
    Levy A
    Trends Endocrinol Metab; 2001 Sep; 12(7):301-7. PubMed ID: 11504669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pancreatic tumours: molecular pathways implicated in ductal cancer are involved in ampullary but not in exocrine nonductal or endocrine tumorigenesis.
    Moore PS; Orlandini S; Zamboni G; Capelli P; Rigaud G; Falconi M; Bassi C; Lemoine NR; Scarpa A
    Br J Cancer; 2001 Jan; 84(2):253-62. PubMed ID: 11161385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Special Issue on Molecular Pathology of Endocrine Neoplasms: Understanding the Basis of Endocrine Pathology Practice.
    Mete O
    Endocr Pathol; 2021 Mar; 32(1):1-2. PubMed ID: 33624136
    [No Abstract]   [Full Text] [Related]  

  • 10. The molecular genetics of endocrine tumours.
    Learoyd DL; Twigg SM; Zedenius JV; Robinson BG
    J Pediatr Endocrinol Metab; 1998; 11(2):195-228. PubMed ID: 9642636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Syndromes that Link the Endocrine System and Genitourinary Tract.
    Özlük Y; Kılıçaslan I
    Turk Patoloji Derg; 2015; 31 Suppl 1():155-71. PubMed ID: 26177325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overview of Genetically Determined Diseases/Multiple Endocrine Neoplasia Syndromes Predisposing to Endocrine Tumors.
    Decmann A; Patócs A; Igaz P
    Exp Suppl; 2019; 111():105-127. PubMed ID: 31588530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The genetics of endocrine neoplasia.
    Nagy R
    Curr Probl Cancer; 2014; 38(6):262-73. PubMed ID: 25497412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progress in Endocrine Neoplasia.
    Wells SA
    Clin Cancer Res; 2016 Oct; 22(20):4981-4988. PubMed ID: 27742784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Focus on hereditary endocrine neoplasia.
    Spiegel AM
    Cancer Cell; 2004 Oct; 6(4):327-32. PubMed ID: 15488756
    [No Abstract]   [Full Text] [Related]  

  • 16. A transgenic mouse bearing an antisense construct of regulatory subunit type 1A of protein kinase A develops endocrine and other tumours: comparison with Carney complex and other PRKAR1A induced lesions.
    Griffin KJ; Kirschner LS; Matyakhina L; Stergiopoulos SG; Robinson-White A; Lenherr SM; Weinberg FD; Claflin ES; Batista D; Bourdeau I; Voutetakis A; Sandrini F; Meoli EM; Bauer AJ; Cho-Chung YS; Bornstein SR; Carney JA; Stratakis CA
    J Med Genet; 2004 Dec; 41(12):923-31. PubMed ID: 15591278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pituitary tumor-transforming gene and its binding factor in endocrine cancer.
    Smith VE; Franklyn JA; McCabe CJ
    Expert Rev Mol Med; 2010 Dec; 12():e38. PubMed ID: 21129230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein kinase A alterations in endocrine tumors.
    Yu B; Ragazzon B; Rizk-Rabin M; Bertherat J
    Horm Metab Res; 2012 Sep; 44(10):741-8. PubMed ID: 22752956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and molecular genetics of Carney complex.
    Rothenbuhler A; Stratakis CA
    Best Pract Res Clin Endocrinol Metab; 2010 Jun; 24(3):389-99. PubMed ID: 20833331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pathogenic patterns of genetic predisposition to endocrine tumors].
    Calender A
    Nephrol Ther; 2006 Jan; 2 Suppl 2():S127-36. PubMed ID: 17373213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.